Reported Dec 30, 2020 · Terminated
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX…
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Akebia Therapeutics dba Keryx Biopharmaceutials, Inc · 245 1st St · Cambridge, MA · 02142-1200
Is this the product you have?
- Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only
- Manufactured for and distributed byKERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
- Lot codes and dates
- Lot Number
9062exp. date Feb 2021
- Lot Number
- Amount recalled
- 2,170 bottles
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Akebia Therapeutics dba Keryx… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.